Mode
Text Size
Log in / Sign up
N/A Completed N=26 Randomized Treatment

Feasibility of a Campaign Intervention Compared to a Standard Behavioral Weight Loss Intervention in Overweight and Obese Adults

Source: ClinicalTrials.gov NCT01803737 ↗
Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Feb 2014
Primary outcomePrimary: Change in Body Weight — -5.6; -3.1 kg

Summary

The purpose of this study is to examine the feasibility of a campaign intervention for weight management compared to a standard behavioral weight loss intervention in overweight and obese adults.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Body Weight
-5.6; -3.1
SECONDARY
Change in Physical Activity
983.3; 776.3
SECONDARY
Change in Dietary Intake: Kcals/Day
474.8; 242.5
SECONDARY
Change in Dietary Intake: % Fat
-3.26; -0.00
SECONDARY
Change in Dietary Intake: % Protein
0.73; 0.44
SECONDARY
Change in Dietary Intake: % Carbohydrate
0.64; 0.90
SECONDARY
Completion of Self-monitoring of Dietary Intake and Physical Activity
91.6; 60.1
SECONDARY
Change in Weight Loss Self-efficacy
28.3; 16.3
SECONDARY
Autonomous and Controlled Motivation
6.3; 5.3; 2.9; 2.9

Eligibility Criteria

Inclusion Criteria

  • 18-55 years of age
  • Body mass index (BMI) ranging from ≥25.0 kg/m² to 45.0 kg/m²
  • Ability to provide informed consent

Exclusion Criteria

  • Regular exercise participation of at least 20 minutes per day on at least 3 days per week during the previous six months.
  • Participation in a previous physical activity or weight management research project in the previous 6 months.
  • Weight loss of ≥5% of current body weight in the previous 6 months.
  • For women, those currently pregnant, pregnant during the previous 6 months, or plan on becoming pregnant in the next 6 months.
  • History of myocardial infarction, coronary bypass surgery, angioplasty, or other heart-related surgeries.
  • History of orthopedic or physical complications that would prevent participation in exercise.
  • Currently taking any prescription medication that may affect metabolism and/or body weight (e.g., synthroid).
  • Currently being treated for any condition that could affect body weight, such as coronary heart disease, diabetes mellitus, uncontrolled hypertension, cancer, depression, and anxiety.
  • Currently being treated for any psychological issues or problems, taking any psychotropic medications, or receiving treatment with psychotropic medications within the previous 6 months.
  • Resting systolic blood pressure ≥150mmHg or diastolic blood pressure ≥100mmHg. Subjects with controlled hypertension will be allowed to participate if they obtain a medical doctor's written consent to ensure that it is safe to participate in a weight loss intervention.
  • Currently do not have access to a computer and the Internet.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01803737). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search